Fund Holdings — Fairmount Funds Management LLC

Total Portfolio Value:
$1.23B
Total Bought:
$241.07M
Total Sold:
$85.26M
Net Transaction:
+$155.80M
Notable People:
Tomas Kiselak, Peter Evan Harwin
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Axsome Therapeutics, Inc.(AXSM)2,360,0772,360,0770$189.99M$212.10M17.20%+$22.11M
Nuvalent Inc1,924,6261,687,064-237,562$146.00M$172.59M13.99%+$26.58M
Apogee Therapeutics Inc2,048,6472,048,6470$80.61M$120.34M9.76%+$39.72M
Spyre Therapeutics, Inc.(SYRE)4,018,1014,018,1010$94.47M$118.17M9.58%+$23.71M
Enliven Therapeutics Inc3,202,7983,202,7980$74.85M$81.80M6.63%+$6.95M
Kiniksa Pharmaceuticals International, plcCL A(KNSA)3,204,8413,204,8410$59.83M$80.09M6.49%+$20.25M
Oruka Therapeutics, Inc.(ORKA)03,211,922+3,211,922$0$78.72M6.38%+$78.72M
Viridian Therapeutics, Inc.(VRDN)1,845,8133,445,813+1,600,000$24.01M$78.39M6.36%+$54.38M
Dianthus Therapeutics, Inc.(DNTH)2,762,8372,700,691-62,146$71.50M$73.94M6.00%+$2.44M
Cogent Biosciences, Inc.(COGT)6,225,6416,225,6410$52.48M$67.24M5.45%+$14.75M
Day One Biopharmaceuticals Inc
COM
03,103,448+3,103,448$0$43.23M3.51%+$43.23M
Astria Therapeutics Inc3,554,1293,554,1290$32.34M$39.13M3.17%+$6.79M
Bicara Therapeutics Inc01,284,169+1,284,169$0$32.71M2.65%+$32.71M
Zenas BioPharma, Inc.(ZBIO)01,892,806+1,892,806$0$32.03M2.60%+$32.03M
Bicycle Therapeutics PlcADS1,069,199123,538-945,661$21.64M$2.80M0.23%-$18.84M
Protagonist Therapeutics Inc931,8900-931,890$32.29M$0—-$32.29M
Terns Pharmaceuticals Inc748,9960-748,996$5.10M$0—-$5.10M
Page 1 of 1
Fairmount Funds Management LLC — 13F Holdings — Q3 2024 | TickerTrail